This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Hemoglobin Measured by "Orsense NBM-200MP" Device and Laboratory Measurement

This study has been completed.
Information provided by (Responsible Party):
Hopital Foch Identifier:
First received: March 19, 2011
Last updated: November 2, 2016
Last verified: November 2016
The purpose of this study is to compare the hemoglobin results obtained with the "Orsense NBM-200MP" device and the Clinical Laboratory.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Comparison of the Hemoglobin Results Obtained With the "Orsense NBM-200MP" Device and the Clinical Laboratory

Further study details as provided by Hopital Foch:

Primary Outcome Measures:
  • Hemoglobin measurement using the "Orsense NBM-200MP" device [ Time Frame: 4 months ]

Enrollment: 300
Study Start Date: February 2011
Study Completion Date: March 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
hemoglobin determination
emergency unit patients


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
emergency unit patients requiring an hemoglobin determination

Inclusion Criteria:

  • emergency unit patients requiring an hemoglobin determination

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01321593

Hôpital Foch
Suresnes, France, 92150
Sponsors and Collaborators
Hopital Foch
Study Chair: Marc Fischler, MD Hôpital Foch
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Hopital Foch Identifier: NCT01321593     History of Changes
Other Study ID Numbers: 2010/28
2010-A00541-38 ( Other Identifier: ANSM )
Study First Received: March 19, 2011
Last Updated: November 2, 2016

Additional relevant MeSH terms:
Disease Attributes
Pathologic Processes processed this record on August 23, 2017